Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AdaptHealth Corp.
Report date September 20, 2024 · Filed September 24, 2024
Section 16 reporting ended · disclosed 2024-09-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 212,611 |
Reported balance
After 2024-09-20 transaction · row 1
1 source rowRow 1 · 2024-09-20 · Sale · Disposed 25,000 · Balance 212,611 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.23 to $11.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.23 to $11.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 20, 2024 Filed Sep 24, 2024 22:25 UTC | AdaptHealth Corp. AHCO · Entity 5183 | SaleCommon Stock | 25,000 | $11.24 | $281,000.00 |
DisclosureSEC source: 0001104659-24-102511 · tm2424626-3_4seq1.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · Former Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,611 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.23 to $11.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| February 05, 2024 Filed Feb 8, 2024 00:02 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 71,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-011741 · tm245420-6_4seq1.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,611 F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 22:21 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 19,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031872 · tm235381-15_4seq1.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,272 F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 23:33 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Disposition to issuerCommon Stock | 1,061 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-001025 · tm2232561-6_4seq1.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · COO - Centralized Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,087 F1 · shares: The reporting person surrendered 1,061 shares of restricted stock due to the company's final determination that certain stock price performance criteria of the company were not achieved. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 00:38 UTC | AdaptHealth Corp. AHCO · Entity 5183 | SaleCommon Stock | 75,000 | $22.52 | $1,689,060.00 |
DisclosureSEC source: 0001104659-22-118832 · tm2230341-1_4seq1.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · COO - Centralized Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,148 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.36 to $22.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 21:35 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 4,973 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-025197 · tm225219-10_4seq1.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · COO - Centralized Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,148 Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 22:09 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 10,422 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-011425 · tm225219-8_4seq1.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · COO - Centralized Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,175 F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting. Read SEC document |
| December 31, 2021 Filed Jan 5, 2022 02:03 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 6,188 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-001084 · tm2136673-1_4seq1.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · COO - Centralized Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,753 F1 · kind: Shares issued as contingent consideration pursuant to the Agreement and Plan of Merger, dated as of July 8, 2019, as amended, by and among the issuer, BM AH Holdings, LLC, Access Point Medical, Inc., DFB Merger Sub LLC, AdaptHealth Holdings LLC, Clifton Bay Offshore Investments L.P., BlueMountain Foinaven Master Fund L.P., BMSB L.P., BlueMountain Fursan Fund L.P. and AH Representative LLC (the "Merger Agreement"). F2 · price: Pursuant to the Merger Agreement, the reporting person was entitled to receive the reporting person's pro rata portion of 1,000,000 shares of stock of the issuer based on certain conditions having been satisfied. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 23:59 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 955 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-125928 · tm2129900-7_4seq1.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · COO - Centralized Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,565 Read SEC document |
| August 20, 2021 Filed Aug 23, 2021 20:10 UTC | AdaptHealth Corp. AHCO · Entity 5183 | SaleCommon Stock | 49,443 | $23.16 | $1,145,198.77 |
DisclosureSEC source: 0001104659-21-108564 · tm2124383-2_4seq1.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,610 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.495 to $23.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:08 UTC | AdaptHealth Corp. AHCO · Entity 5183 | SaleClass A Common Stock | 55,000 | $37.23 | $2,047,732.50 |
DisclosureSEC source: 0001104659-21-037116 · tm214849-18_4seq1.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,053 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.89 to $37.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| January 28, 2021 Filed Feb 2, 2021 03:00 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantEmployee Stock Option (right to buy) · Derivative | 69,444 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-010444 · tm214849-7_4seq1.xml · derivative · entry 2 Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,444 Underlying: Class A Common Stock · 69,444 shares Expires not disclosed F2 · derivative.exercise_price: On December 19, 2019, the reporting person was granted an option to purchase 208,333 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 69,444 shares. F2 · price: On December 19, 2019, the reporting person was granted an option to purchase 208,333 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 69,444 shares. F2 · derivative.exercise_date: On December 19, 2019, the reporting person was granted an option to purchase 208,333 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 69,444 shares. F2 · derivative.expiration_date: On December 19, 2019, the reporting person was granted an option to purchase 208,333 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 69,444 shares. Read SEC document |
| January 28, 2021 Filed Feb 2, 2021 03:00 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantClass A Common Stock | 8,719 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-010444 · tm214849-7_4seq1.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,053 F1 · balance_after: Includes 6,188 shares issued as contingent consideration pursuant to the Agreement and Plan of Merger, dated as of July 8, 2019, as amended, by and among the issuer, BM AH Holdings, LLC, Access Point Medical, Inc., DFB Merger Sub LLC, AdaptHealth Holdings LLC, Clifton Bay Offshore Investments L.P., BlueMountain Foinaven Master Fund L.P., BMSB L.P., BlueMountain Fursan Fund L.P. and AH Representative LLC. Read SEC document |
| January 28, 2021 Filed Feb 12, 2021 22:44 UTC Amendment | AdaptHealth Corp. AHCO · Entity 5183 | GrantEmployee Stock Option (right to buy) · Derivative | 208,333 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001104659-21-022176 · tm214849-16_4aseq1.xml · derivative · entry 1 Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,333 Underlying: Class A Common Stock · 208,333 shares Expires 2029-12-19 F1 · shares: On December 19, 2019, the reporting person was granted an option to purchase 208,333 shares of Class A Common Stock of the issuer, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. The performance criteria for 2020 were met, resulting in the vesting of the option as to 208,333 shares in three equal annual installments on each of December 31, 2020, December 31, 2021 and December 31, 2022. This amendment is being filed to correct inadvertent typographical errors in the number of shares vested under the option held by the reporting person. F1 · derivative.exercise_date: On December 19, 2019, the reporting person was granted an option to purchase 208,333 shares of Class A Common Stock of the issuer, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. The performance criteria for 2020 were met, resulting in the vesting of the option as to 208,333 shares in three equal annual installments on each of December 31, 2020, December 31, 2021 and December 31, 2022. This amendment is being filed to correct inadvertent typographical errors in the number of shares vested under the option held by the reporting person. Read SEC document |
| January 01, 2021 Filed Jan 6, 2021 01:05 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Exercise / conversionClass B Common Stock · Derivative | 89,922 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-001156 · tm211602-2_4seq1.xml · derivative · entry 2 Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 89,922 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). F2 · price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). F2 · derivative.exercise_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). F2 · derivative.expiration_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). Read SEC document |
| January 01, 2021 Filed Jan 6, 2021 01:05 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Exercise / conversionClass A Common Stock | 89,922 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-001156 · tm211602-2_4seq1.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares of Class A Common Stock of the Issuer issued upon an exchange of an equivalent number of shares of Class B Common Stock of the Issuer pursuant to the terms of that certain Exchange Agreement, dated as of November 8, 2019, by and among the Issuer, AdaptHealth Holdings LLC and the other parties thereto (together with the same number of common units of AdaptHealth Holdings LLC). Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Exercise / conversionClass B Common Stock · Derivative | 149,871 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-133876 · tm2038090-3_4seq1.xml · derivative · entry 4 Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,922 Underlying: Class A Common Stock · 149,871 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 119,896 of the common units of AdaptHealth Holdings LLC held by the reporting person are subject to vesting, with 29,974 units vesting on each of the first four anniversaries of May 20, 2019. F4 · price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 119,896 of the common units of AdaptHealth Holdings LLC held by the reporting person are subject to vesting, with 29,974 units vesting on each of the first four anniversaries of May 20, 2019. F4 · derivative.exercise_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 119,896 of the common units of AdaptHealth Holdings LLC held by the reporting person are subject to vesting, with 29,974 units vesting on each of the first four anniversaries of May 20, 2019. F4 · derivative.expiration_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 119,896 of the common units of AdaptHealth Holdings LLC held by the reporting person are subject to vesting, with 29,974 units vesting on each of the first four anniversaries of May 20, 2019. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | SaleClass A Common Stock | 12,000 | $34.91 | $418,920.00 |
DisclosureSEC source: 0001104659-20-133876 · tm2038090-3_4seq1.xml · nonDerivative · entry 3 Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,224 F3 · price: This transaction was executed in multiple trades at prices ranging from $34.86 to $35.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Disposition to issuerClass A Common Stock | 45,000 | $29.36 | $1,321,200.00 |
DisclosureSEC source: 0001104659-20-133876 · tm2038090-3_4seq1.xml · nonDerivative · entry 2 Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,224 F2 · shares: Represents the number of shares of Class A Common Stock otherwise issuable upon the exchange of shares of Class B Common Stock of the Issuer (together with the same number of common units of AdaptHealth Holdings LLC) with respect to which the Issuer elected to deliver cash in lieu of shares of Class A Common Stock pursuant to the terms of the Exchange Agreement. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Exercise / conversionClass A Common Stock | 149,871 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-133876 · tm2038090-3_4seq1.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares of Class A Common Stock of the Issuer issued upon an exchange of an equivalent number of shares of Class B Common Stock of the Issuer pursuant to the terms of that certain Exchange Agreement, dated as of November 8, 2019 (the "Exchange Agreement"), by and among the Issuer, AdaptHealth Holdings LLC and the other parties thereto (together with the same number of common units of AdaptHealth Holdings LLC). Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 02:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantClass A Common Stock | 62,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029844 · a4.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,353 Read SEC document |
| November 21, 2019 Filed Nov 26, 2019 02:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantClass A Common Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-067181 · a4.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,417 Read SEC document |
| November 08, 2019 Filed Nov 14, 2019 02:24 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherWarrants · Derivative | 11,617 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001104659-19-063552 · a4.xml · derivative · entry 3 Rietkerk Shaw · CIK 0001792695 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,617 Underlying: Class A Common Stock · 11,617 shares Expires not disclosed F1 · kind: Securities transferred to the reporting person in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. F3 · derivative.exercise_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. F3 · derivative.expiration_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. Read SEC document |
| November 08, 2019 Filed Nov 14, 2019 02:24 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantClass B Common Stock · Derivative | 239,793 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-19-063552 · a4.xml · derivative · entry 2 Rietkerk Shaw · CIK 0001792695 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,793 Underlying: Class A Common Stock · 239,793 shares Expires not disclosed F2 · derivative.exercise_price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 119,896 of the common units of the common units of AdaptHealth Holdings LLC held by the reporting person are subject to vesting, with 29,974 units vesting on each of the first four anniversaries of May 20, 2019. F2 · price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 119,896 of the common units of the common units of AdaptHealth Holdings LLC held by the reporting person are subject to vesting, with 29,974 units vesting on each of the first four anniversaries of May 20, 2019. F2 · derivative.exercise_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 119,896 of the common units of the common units of AdaptHealth Holdings LLC held by the reporting person are subject to vesting, with 29,974 units vesting on each of the first four anniversaries of May 20, 2019. F2 · derivative.expiration_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 119,896 of the common units of the common units of AdaptHealth Holdings LLC held by the reporting person are subject to vesting, with 29,974 units vesting on each of the first four anniversaries of May 20, 2019. Read SEC document |
| November 08, 2019 Filed Nov 14, 2019 02:24 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherClass A Common Stock | 19,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-063552 · a4.xml · nonDerivative · entry 1 Rietkerk Shaw · CIK 0001792695 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,417 F1 · kind: Securities transferred to the reporting person in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.